0001773751-22-000099.txt : 20220317
0001773751-22-000099.hdr.sgml : 20220317
20220317191535
ACCESSION NUMBER: 0001773751-22-000099
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220315
FILED AS OF DATE: 20220317
DATE AS OF CHANGE: 20220317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maltz Jules A.
CENTRAL INDEX KEY: 0001553254
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38986
FILM NUMBER: 22750478
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD
STREET 2: BUILDING 2, SUITE 250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hims & Hers Health, Inc.
CENTRAL INDEX KEY: 0001773751
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
BUSINESS PHONE: 415-851-0195
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
FORMER COMPANY:
FORMER CONFORMED NAME: Oaktree Acquisition Corp.
DATE OF NAME CHANGE: 20190412
4
1
wf-form4_164755891771303.xml
FORM 4
X0306
4
2022-03-15
0
0001773751
Hims & Hers Health, Inc.
HIMS
0001553254
Maltz Jules A.
2269 CHESTNUT STREET, #523
SAN FRANCISCO
CA
94123
1
0
1
0
Class A Common Stock
2022-03-15
4
M
0
9794
A
19001
D
Class A Common Stock
53974
I
Held by Institutional Venture Partners XV Executive Fund, L.P.
Class A Common Stock
10147758
I
Held by Institutional Venture Partners XV, L.P.
Class A Common Stock
10201746
I
Held by Institutional Venture Partners XVI, L.P.
Restricted Stock Unit
2022-03-15
4
M
0
17
0
D
Class A Common Stock
17.0
52
D
Restricted Stock Unit
2022-03-15
4
M
0
871
0
D
Class A Common Stock
871.0
2614
D
Restricted Stock Unit
2022-03-15
4
M
0
8906
0
D
Class A Common Stock
8906.0
26721
D
The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.
The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer.
/s/ Soleil Boughton, Attorney-in-Fact
2022-03-17